Insider · CIK 0001479386

Viswanathan Ravi

Reports to the SEC for 38 companies · TIMONIUM, MD

sec.gov

Transactions

Companies

Filings

CIK

0001479386

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-10-10	ESTCElastic N.V.C Conversion	10% Owner	CConversion	+4.16M sh	—	—	4,155,995
2018-10-10	ESTCElastic N.V.C Conversion	10% Owner	CConversion	+1.53M sh	—	—	1,528,117
2018-10-10	ESTCElastic N.V. · Series C Convertible Preference SharesC Conversion	10% Owner	CConversion	−4.16M sh	—	—	0
2018-10-10	ESTCElastic N.V. · Series D Convertible Preference SharesC Conversion	10% Owner	CConversion	−1.53M sh	—	—	0
2018-09-07	ADAPAdaptimmune Therapeutics PLCP Purchase	10% Owner	PPurchase	+3M sh	$1.67	+$5M	82,978,668
2018-09-07	ADAPAdaptimmune Therapeutics PLCP Purchase	10% Owner	PPurchase	+12M sh	$1.67	+$20M	12,000,000
2018-08-21	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+664K sh	$2.26	+$1.5M	18,698,038
2018-07-19	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+50.6K sh	$2.00	+$101K	18,034,322
2018-07-18	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+200K sh	$1.95	+$391K	17,983,722
2018-06-28	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+187K sh	$2.10	+$393K	17,783,722
2018-06-27	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+5,295 sh	$2.15	+$11.4K	17,596,592
2018-05-30	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+275 sh	$2.15	+$591.25	17,591,297
2018-05-25	ARDXARDELYX, INC.A Award	10% Owner	AAward	+417K sh	$4.00	+$1.67M	3,082,186
2018-05-25	ARDXARDELYX, INC.A Award	10% Owner	AAward	+417K sh	$4.00	+$1.67M	3,082,186
2018-05-21	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+32.2K sh	$2.14	+$69.1K	17,591,022
2018-05-18	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+20.1K sh	$2.14	+$42.9K	17,558,822
2018-05-17	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+184K sh	$2.13	+$391K	17,538,722
2018-05-08	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+70.9K sh	$2.13	+$151K	17,354,543
2018-05-01	MULESOFT, INCC Conversion	10% Owner	CConversion	+12.7M sh	—	—	12,679,970
2018-05-01	MULESOFT, INCU Disposition from Tender	10% Owner	UDisposition from Tender	−12.7M sh	—	—	0
2018-05-01	MULESOFT, INCC Conversion	10% Owner	CConversion	+2.58M sh	—	—	2,576,939
2018-05-01	MULESOFT, INCU Disposition from Tender	10% Owner	UDisposition from Tender	−2.58M sh	—	—	0
2018-05-01	MULESOFT, INCC Conversion	10% Owner	CConversion	+859K sh	—	—	858,978
2018-05-01	MULESOFT, INCU Disposition from Tender	10% Owner	UDisposition from Tender	−859K sh	—	—	0
2018-05-01	MULESOFT, INCClass B Common StockC Conversion	10% Owner	CConversion	−12.7M sh	—	—	0
2018-05-01	MULESOFT, INCClass B Common StockC Conversion	10% Owner	CConversion	−2.58M sh	—	—	0
2018-05-01	MULESOFT, INCClass B Common StockC Conversion	10% Owner	CConversion	−859K sh	—	—	0
2018-04-23	Surface Oncology, Inc.C Conversion	10% Owner	CConversion	+3.18M sh	—	—	3,179,544
2018-04-23	Surface Oncology, Inc.P Purchase	10% Owner	PPurchase	+133K sh	$15.00	+$2M	3,312,877
2018-04-23	Surface Oncology, Inc.Series A Preferred StockC Conversion	10% Owner	CConversion	−7M sh	—	—	0
2018-04-10	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+203K sh	$2.46	+$500K	17,283,670
2018-04-09	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+32.1K sh	$2.43	+$78.1K	17,080,470
2018-04-06	AVEO PHARMACEUTICALS, INC.P Purchase	10% Owner	PPurchase	+686K sh	$2.24	+$1.54M	17,048,370
2018-03-27	Tracon Pharmaceuticals, Inc.P Purchase	10% Owner	PPurchase	+708K sh	$2.70	+$1.91M	3,466,003
2018-03-27	Tracon Pharmaceuticals, Inc.Warrant to Purchase Common StockP Purchase	10% Owner	PPurchase	+708K sh	$0.13	+$88.5K	707,964
2018-03-27	ADAPAdaptimmune Therapeutics PLCP Purchase	10% Owner	PPurchase	+6M sh	$1.92	+$11.5M	79,978,672
2018-03-26	ADAPAdaptimmune Therapeutics PLCP Purchase	10% Owner	PPurchase	+571K sh	$1.90	+$1.09M	73,978,672
2018-03-23	ADAPAdaptimmune Therapeutics PLCP Purchase	10% Owner	PPurchase	+294K sh	$1.95	+$572K	73,407,508
2018-03-22	ADAPAdaptimmune Therapeutics PLCP Purchase	10% Owner	PPurchase	+870K sh	$1.90	+$1.66M	73,113,418
2018-03-21	ADAPAdaptimmune Therapeutics PLCP Purchase	10% Owner	PPurchase	+105K sh	$1.81	+$190K	72,243,844
2018-03-09	Cascadian Therapeutics, Inc.U Disposition from Tender	10% Owner	UDisposition from Tender	−10.9M sh	—	—	0
2018-03-06	TESARO, Inc.P Purchase	10% Owner	PPurchase	+12.6K sh	$59.82	+$756K	9,681,129
2018-03-06	TESARO, Inc.P Purchase	10% Owner	PPurchase	+3,159 sh	$59.82	+$189K	739,516
2018-03-05	TESARO, Inc.P Purchase	10% Owner	PPurchase	+30.3K sh	$58.28	+$1.77M	9,649,647
2018-03-05	TESARO, Inc.P Purchase	10% Owner	PPurchase	+1,600 sh	$59.15	+$94.6K	9,651,247
2018-03-05	TESARO, Inc.P Purchase	10% Owner	PPurchase	+17.2K sh	$59.76	+$1.03M	9,668,495
2018-03-05	TESARO, Inc.P Purchase	10% Owner	PPurchase	+7,557 sh	$58.28	+$440K	731,646
2018-03-05	TESARO, Inc.P Purchase	10% Owner	PPurchase	+400 sh	$59.15	+$23.7K	732,046
2018-03-05	TESARO, Inc.P Purchase	10% Owner	PPurchase	+4,311 sh	$59.76	+$258K	736,357
2018-03-02	TESARO, Inc.P Purchase	10% Owner	PPurchase	+26.3K sh	$54.32	+$1.43M	9,590,988

Recent filings

Accepted (ET)
Oct 104
Viswanathan Ravi0001209191-18-054723
SEC(opens sec.gov)
Sep 104
Viswanathan Ravi0001209191-18-050293
SEC(opens sec.gov)
Aug 224
Viswanathan Ravi0001209191-18-047972
SEC(opens sec.gov)
Jul 204
Viswanathan Ravi0001209191-18-043489
SEC(opens sec.gov)
Jun 284
Viswanathan Ravi0001209191-18-039969
SEC(opens sec.gov)
May 304
Viswanathan Ravi0001209191-18-034182
SEC(opens sec.gov)
May 304
Viswanathan Ravi0001209191-18-034194
SEC(opens sec.gov)
May 214
Viswanathan Ravi0001209191-18-031990
SEC(opens sec.gov)
May 104
Viswanathan Ravi0001209191-18-029305
SEC(opens sec.gov)
May 94
Viswanathan Ravi0001209191-18-028795
SEC(opens sec.gov)

Companies

Address

1954 GREENSPRING DRIVE SUITE 600

TIMONIUM, MD, 21093